Merida Capital Partners is a private equity investment firm targeting fundamental growth drivers underpinning the rapid development of the cannabis industry. Our investment emphasis focuses on cultivation technologies, products and services associated with the evolution of cannabis as an agricultural product, a natural plant-based medicine, a constituent in pharmaceutical formulations, and a recreational consumer product.
The Merida team has members who have been working with state legal cannabis companies since 2009 and investing in cannabis-related companies since 2012. We have honed our investing philosophy through our immersion in the most complex areas of the cannabis industry, the state-regulated licensing process for medical cultivation and cannabis-based pharmaceutical development.
Our team has competed for and won limited licenses in two of the strictest medical-only states in the United States, and married that operational experience with successful private equity track records and decades of experience in the traditional industries of technology, real estate, structured finance and banking.
While we have deep experience in the entire cannabis supply chain, our investment thesis is grounded primarily in four distinct verticals: Medical cultivation, cultivation infrastructure, data and technology services and pharmaceutical development and life sciences. We seek compelling long-termvalue as the industry matures by investing in well-managed, revenue generating companies offering cannabis-based businesses essential products or services.